Latest Product News
Predictive Oncology and Cancer Research Horizons Partnered To Develop of Cancer Drugs
Predictive Oncology Inc. together with Cancer Research Horizons, announce that they have partnered to drive the development of oncology drugs utilizing Predictive Oncology’s PEDAL™ platform.
Owlstone Medical Enters Partnership To Develop Probes for Early Cancer Detection
Owlstone Medical has announced that it has entered into a Research Agreement with Bicycle Therapeutics plc.
OGT First To Achieve IVDR-Certification for FISH Probes
OGT announces that IVDR certification has been granted for eight CytoCell® fluorescence in situ hybridization (FISH) probes important for patient management in hematological cancers and prenatal conditions.
SonALAsense Announces Completion of First Cohort in Phase 2 Study of Sonodynamic Therapy for Recurrent Glioblastoma
SonALAsense has announced that the first cohort in Sonodynamic Therapy (SDT)-202 was fully enrolled.
Personalis Selected for Clinical Research After Successful Evaluation of Residual Disease Assay
Personalis, Inc. has announced it will continue its collaboration with AstraZeneca to explore ultra-sensitive molecular residual disease measurement, including clinically relevant and personalized variant tracking, for clinical research and drug development.
TransCure bioServices Delivers CDX Mouse Models To Advance AML Preclinical Studies
TransCure bioServices has developed cell line-derived xenograft mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia.
Voltron Therapeutics, Inc. Announces Sponsored Research Agreement With the Massachusetts General Hospital, Harvard Medical School, To Initiate a Pre-Clinical Immuno-Oncology Trial
Voltron Therapeutics, Inc. has signed a new Sponsored Research Agreement with the Vaccine and Immunotherapy Center at Massachusetts General Hospital, Harvard Medical School to initiate a pre-clinical immuno-oncology trial targeting prostate stem cell antigen in prostate, renal cell and urothelial cancers, adding important potential indications to its growing pipeline.
Akamis Bio, Parker Institute for Cancer Immunotherapy and Cancer Research Institute Expand Partnership
Akamis Bio has announced an expansion of its ongoing partnership with the Parker Institute for Cancer Immunotherapy to include a clinical collaboration with the Cancer Research Institute that will focus on advancing novel treatments for pancreatic cancer.
Cytek® Biosciences Partners With Bio-Rad To Expand Reagent Portfolios
Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. has announced that it has entered into a strategic partnership with Bio-Rad Laboratories, Inc.
TransCure bioServices Offers BioVolume 3D Imaging
The new service is a world first in 3D imaging, allowing the measurement and visualization of tumor growth in animal models across preclinical research, oncology and drug development.